Adrian Van Bakel to Double-Blind Method
This is a "connection" page, showing publications Adrian Van Bakel has written about Double-Blind Method.
Connection Strength
0.039
-
A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur J Heart Fail. 2017 10; 19(10):1321-1332.
Score: 0.027
-
Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med. 2005 Jun 30; 352(26):2705-13.
Score: 0.012